Contraception
Volume 77, Issue 4 , Pages 294-298, April 2008

High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy☆

  • Beverley A. Lawton

      Affiliations

    • Women's Health Research Centre, Department of Primary Health Care and General Practice, Wellington School of Medicine and Health Sciences, PO Box 7343, Wellington South, New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 4 385 5995x4893; fax: +64 4 385 5473.
    • ,
  • Sally B. Rose

      Affiliations

    • Women's Health Research Centre, Department of Primary Health Care and General Practice, Wellington School of Medicine and Health Sciences, PO Box 7343, Wellington South, New Zealand
    • ,
  • Collette Bromhead

      Affiliations

    • Molecular Biology Department, Aotea Pathology, Wellington, New Zealand
    • ,
  • Louise A. Gaitanos

      Affiliations

    • Molecular Biology Department, Aotea Pathology, Wellington, New Zealand
    • ,
  • E. Jane MacDonald

      Affiliations

    • WIPA Wellington Sexual Health Service, Newtown, Wellington
    • ,
  • Kim A. Lund

      Affiliations

    • Wellington Hospital, Capital and Coast District Health Board, New Zealand

Received 5 October 2007; received in revised form 20 December 2007; accepted 21 December 2007. published online 27 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was funded by a grant from the University of Otago and from ISTAR (a nonprofit organization that imports and distributes mifepristone in New Zealand). The authors would like to thank the women who participated in the study and the staff at the Wellington Hospital TOP unit and Aotea Pathology for their assistance with this study. We gratefully acknowledge the assistance of Dr Christoph Noppen, Viollier AG, Basel, Switzerland, for the MG297 assay, and Roche Diagnostics New Zealand for supplying PCR reagents.

PII: S0010-7824(08)00002-4

doi:10.1016/j.contraception.2007.12.002

Contraception
Volume 77, Issue 4 , Pages 294-298, April 2008

Article Tools

* Image Usage & Resolution